For example, it's been shown that prime-dose CsA—but not small dose CsA—specifically inhibits the expression of NFATc1 and IL-two in human T cells from stimulated entire blood samples, assessed by move cytometry (23). For that reason, not like other cytotoxic immune suppressors, CsA doesn't get rid of the immune effector https://fredericks999fqc1.wikipresses.com/user